Clinical Trials at Medycyna Milorzab
During the past decade, Medycyna Milorzab conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medycyna Milorzab"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Medycyna Milorzab
According to Clinical.Site data, the most researched conditions in "Medycyna Milorzab" are
"Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Alzheimer's Disease" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Medycyna Milorzab" in a lesser frequency.
Clinical Trials Intervention Types at Medycyna Milorzab
Most popular intervention types in "Medycyna Milorzab" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "AVP-786" (2 trials), "Placebo" (2 trials), "Lanabecestat" (1 trials) and "Luvadaxistat" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medycyna Milorzab
The vast majority of trials in "Medycyna Milorzab" are
4 trials for "All" genders.
Clinical Trials Status at Medycyna Milorzab
Currently, there are NaN active trials in "Medycyna Milorzab".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Medycyna Milorzab,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Medycyna Milorzab, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".